News and Announcements >
Abstract Submission Deadline Extended. Abstracts must be received no later than 1:00 pm ET on Monday, January 11, 2021.
December, 2020 -- Currently, SNMMI is planning to offer a hybrid approach for our 2021 meeting, providing both an in-person and virtual option. This ensures that abstract authors will have the opportunity to present their research to an international audience of leading nuclear medicine and molecular imaging professionals—virtually or in person.
We continue to monitor the unique and difficult conditions affecting our world, recognizing that in-person events or travel still may not be possible in June, even as conditions improve and vaccine distribution expands. If conditions warrant, the meeting may transition to a 100% virtual event. We will continue to keep you informed about any changes, and hope to have a decision on the status of the meeting in February 2021.